References:
1. Pavone P, Praticò AD, Pavone V, Lubrano R, Falsaperla R, Rizzo R, et
al. Ataxia in children: Early recognition and clinical evaluation. Ital
J Pediatr [Internet]. 2017;43:1–9. Available from:
http://dx.doi.org/10.1186/s13052-016-0325-9
2. K.P. D, Kishore A. Treatable cerebellar ataxias. Clin Park Relat
Disord [Internet]. 2020;3:100053. Available from:
https://doi.org/10.1016/j.prdoa.2020.100053
3. Zhang L, Ashizawa T, Peng D. Primary coenzyme Q10 deficiency due to
COQ8A gene mutations. Mol Genet Genomic Med. 2020;8(10):1–7.
4. Becker AE, Vargas W, Pearson TS. Ataxia with vitamin e deficiency may
present with cervical dystonia. Tremor and Other Hyperkinetic Movements.
2016;2016:1–5.
5. Geberhiwot T, Moro A, Dardis A, Ramaswami U, Sirrs S, Marfa MP, et
al. Consensus clinical management guidelines for Niemann-Pick disease
type C. Orphanet J Rare Dis. 2018;13(1):1–19.
6. Rao VK, DiDonato CJ, Larsen PD. Friedreich’s Ataxia: Clinical
Presentation of a Compound Heterozygote Child with a Rare Nonsense
Mutation and Comparison with Previously Published Cases. Case Rep Neurol
Med. 2018;2018:1–5.
7. Zubarioglu T, Kiykim E, Yesil G, Demircioglu D, Cansever MS,
Yalcinkaya C, et al. Early diagnosed cerebrotendinous xanthomatosis
patients: clinical, neuroradiological characteristics and therapy
results of a single center from Turkey. Acta Neurol Belg.
2019;119(3):343–50.
8. Mancuso M, Orsucci D, Siciliano G, Bonuccelli U. The genetics of
ataxia: Through the labyrinth of the Minotaur, looking for Ariadne’s
thread. J Neurol. 2014;261(SUPPL. 2):528–41.
9. Patterson MC, Vecchio D, Prady H, Abel L, Wraith JE. Miglustat for
treatment of Niemann-Pick C disease: a randomised controlled study.
Lancet Neurol. 2007;6(9):765–72.
10. Wong JC, Walsh K, Hayden D, Eichler FS. Natural history of
neurological abnormalities in cerebrotendinous xanthomatosis. J Inherit
Metab Dis. 2018;41(4):647–56.